Skip to content

PHARMACIE MANDRAGORE

Active
Private limited companyfounded 1994active for 32 yearsPlace Brouez 18, 7390 Quaregnon, BelgiumKBO/BCE: BE 0452.802.037
Summary

PHARMACIE MANDRAGORE has been active since 1994 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €426,866 and a net result of €31,577. Equity has been stable since 2018 (±2.5% per year). Its solvency ranks better than 89% of 5,036 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow ReportCompare
PHARMACIE MANDRAGOREActiveChecked score 89/100
Risk analysis ReportCompare

Overview

Official details

Source: KBO
Status
Active since 01-06-1994 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.067.863.024 7390 Quaregnon, since 16-08-1994
Financial year end
31 December
Peppol
Reachable since 06-06-2025
Company details

Board and ownership

Board
  • ALEXOChair · permanent representative Olivier Delaere
  • SRL SODIAPManaging director · permanent representative Tom Goderis
  • SRL KST PharmaDirector · permanent representative Koen Straetmans
Shareholders
  • SODIAP2025 annual accounts of SODIAP
Board & ownership

Financial position

89 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts 2025
Gross margin
€232,567
▼ 12.7%
Turnover
≈ €1.1m
estimated
Profit
€31,577
▼ 26.2%
Equity
€426,866
▲ 8.0%
Total assets
€532,438
▲ 0.4%
Employees on 31-12-2025
3
=
Filed on 12-05-2026, 80 days before the deadline
Financials
Score breakdownraises riskSize: 3 FTE, total assets €532,438Sector: Retail trade (NACE 47)lowers riskEquity €426,866 (80.2% of total assets)Founded in 1994Show the evidence

Checked score

Score 2025
89 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 65% of micro companies in retail trade (NACE 47)
Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Strong
Solvency 100=
equity 80.2% of total assets
Liquidity 46+4
short-term debt 19.8% · cash 2.0%
Profitability 76-3
return on assets 5.9%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: 0.3% 01-2025: 0.3%● unchanged vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025highest value 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.2%▼ -0.1 percentage points vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.3%▲ +0.1 percentage points vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.2%▼ -0.1 percentage points vs 05-2026lowest value 07-2026: 0.2%● unchanged vs 06-2026lowest value 08-2026: 0.2%● unchanged vs 07-2026lowest value 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026 11-2026: 0.2%● unchanged vs 10-2026
Credit of up to €35,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 4.14 (3.25 in 2024), above the usual 1.5. Short-term debt is 19.8% and cash 2% of total assets. 19.8% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 92% of them on solvency, 46% on liquidity, 64% on profitability and 57% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Size: 3 FTE, total assets €532,438
Companies of this size fail more often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €426,866 (80.2% of total assets)
NBB · annual accounts
lowers risk · Founded in 1994
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €426,866
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-05-2026, 80 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
80 days early
2024
44 days early
2023
49 days early
2022
52 days early
2021
54 days early
2020
47 days early
2019
17 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 49 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 9 June (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 88% of companies in retail tradesector median 36.1% · 5,036 companies 80.2% View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €31,577 8 years View
  • New directorlatest change 19-05-2026 · 2 in office 1 joined View

Companies linked to PHARMACIE MANDRAGORE

Comparable companies

These companies have the same main activity as PHARMACIE MANDRAGORE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €448,000 and €593,000, founded between 1988 and 1993.

CompanyTotal assetsGross margin
PHARMACIE MANDRAGORE Quaregnon€532,438€232,567
HERCOMEX Jurbise€591,927€211,297
ANCIENNE PHARMACIE QUITTELIER Ath€448,413€227,981
Pharmacie SCANU - HAINE Quiévrain€588,243€208,675
PHARMACIE BALDINI Charleroi€592,904€260,332
STRAGIER Ath€562,496€298,584
Pharmacie Schyns Verviers€541,059€226,172
Full comparison

Key facts about PHARMACIE MANDRAGORE
What is the company number of PHARMACIE MANDRAGORE?
The company number of PHARMACIE MANDRAGORE is 0452.802.037. The VAT number is the same number with BE in front: BE 0452.802.037.
Where is PHARMACIE MANDRAGORE based?
The registered office is at Place Brouez 18, 7390 Quaregnon.Company details
What does PHARMACIE MANDRAGORE do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMACIE MANDRAGORE?
The legal form of PHARMACIE MANDRAGORE is Private limited company (BV).
When was PHARMACIE MANDRAGORE founded?
PHARMACIE MANDRAGORE was founded on 01-06-1994.
Is PHARMACIE MANDRAGORE still active?
Yes, PHARMACIE MANDRAGORE is an active enterprise in the KBO register.
How many employees does PHARMACIE MANDRAGORE have?
PHARMACIE MANDRAGORE had an average of 3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of PHARMACIE MANDRAGORE?
The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €232,567 and 51 comparable companies (NACE 477). It probably lies between €740,000 and €2.1m.
Is PHARMACIE MANDRAGORE profitable?
In financial year 2025, PHARMACIE MANDRAGORE made a profit of €31,577.
Where can I find the annual accounts of PHARMACIE MANDRAGORE?
PHARMACIE MANDRAGORE filed 32 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMACIE MANDRAGORE due?
PHARMACIE MANDRAGORE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See the other companies in the same group.PHARMACIE BIA · 40 companies Compare this company with its sector.Sector benchmark

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure